Merck will officially unveil its new Sydney office today with an event headlined by the presence of Dr Frank Stangenberg-Haverkamp, chairman of the company's executive and family boards.
The company recently relocated to its new 'bespoke' office in the innovation hub of Macquarie Park. The move has brought together its more than 120 Sydney-based employees from its Healthcare and Life Science divisions.
Some of the features include 30 combined meeting and collaboration spaces, both formal and informal, with natural light permeating the office and a large internal café-style break-out space for 150 people and an expansive outdoor terrace
The employees will also be joined at today's official event by local federal MP John Alexander OAM, along with guests from the science, technology, academic and health communities.
The event will also include a showcase of the diverse range of products and services provided by the company's three divisions – Healthcare, Life Science and Performance Materials.
“Merck has a 351-year heritage and as the family of owners, we want to build on this successful legacy for future generations. We are proud of our company and its people – about 56,000 curious minds dedicated to human progress. They are pushing the boundaries of possibility to create opportunities for everyone – here in Australia and in more than 60 further countries around the world,” said Dr Stangenberg-Haverkamp.
Merck Healthcare Managing Director and General Manager for Australia/New Zealand, Leah Goodman, said, “This is a very significant milestone in the history of Merck in Australia. This workspace has been designed to encourage productivity, creativity and employee wellbeing, and is aligned with Merck’s global mission to apply its scientific expertise to making a positive difference to people’s lives.”
According to Bradley Simpson, Life Science Managing Director for Australia/New Zealand, “This is an exciting time as Life Science comes together with Healthcare under one roof to further drive the success of our businesses, and of the wider scientific community, demonstrating that Merck is truly a ‘vibrant science and technology company.”
